To compare the safety and efficacy of the two single-tablet regimens ( STRs ) , rilpivirine/emtricitabine/tenofovir disoproxil fumarate ( RPV/FTC/TDF ) and efavirenz/emtricitabine/tenofovir DF ( EFV/FTC/TDF ) , in HIV-1-infected , treatment-naive adults .